期刊文献+

非洛地平对原发性高血压患者血浆一氧化氮和内皮素含量的影响 被引量:3

Effect of felodipine on the plasma nitric oxide and endothelin in patients with essential hypertensive
下载PDF
导出
摘要 目的探讨原发性高血压(EH)患者血浆一氧化氮(NO)和内皮素(ET)含量的变化及非洛地平对其的影响。方法观察72例EH患者(EH组)非洛地平治疗前后血浆NO和ET水平的变化,并与30例正常人(对照组)进行对比分析。结果非洛地平治疗前EH组血浆NO明显低于对照组(P<0.01),血浆ET明显高于对照组(P<0.01)。非洛地平治疗6周后,EH组血压和血浆ET水平明显降低,NO水平明显增高(P<0.01)。结论非洛地平在有效降血压的同时,能使EH患者血浆NO水平升高,ET水平降低,因此对血管内皮功能具有保护作用。 Objective To observe the effect of felodipine on the plasma nitric oxide (NO)and endothelin (ET) in essential hypertensive (EH) patients. Methods The plasma NO and ET and the effect of felodipine intervention were observed in 72 EH,30 healthy subjects were designed as control. Results The plasma NO levels in EH patients were significantly lower than that in normal subjects (P 〈 0.01) ;The plasma ET levels in EH patients were signifcantly higher than that in normal subjects (P〈0. 01), and after felodipine treatment, the blood pressure and the levels of plasma ET were significantly decreased, and the levels of plasma NO were significantly increased in EH patients (P〈 0.01). Conclusion Beside decreasing blood pressure, felodipine can improve the levels of plasma NO and decrease the levels of plasma ET in EH patients. Felodipine has a good protective effect on the endothelial function of EH patients.
出处 《中国心血管杂志》 2005年第4期285-286,289,共3页 Chinese Journal of Cardiovascular Medicine
关键词 非洛地平 原发性高血压 一氧化氮 内皮素 Felodipine Hypertension Nitric oxide Endothelin
  • 相关文献

参考文献10

  • 1高连如,刘国仗,赵云涛,田慧生,石湘芸,杨晔,张继峰,田青,唐朝枢,汤健.内皮衍生舒张因子合成前体降压机制的研究[J].中华心血管病杂志,1996,24(4):245-249. 被引量:14
  • 2Luscher TF, Noll G. Endothelial function as an endpoint in interventional trials, concepts, methods and current date[J ]. Hyperten.s, 1996,14 : 111-121.
  • 3Amal JF, Battle T. The vasodilatary effect of endogenous nitric oxide is a major counter-ragulatory mechanism is the spontaneously hypertensive rat [ J ]. Hyperten.s,1993,11:945-950.
  • 4Bonnardeaux A, Madanal S, Jeunemaitre X, et al. A linkage study of the human endothelial nitric oxide synthesis locus in essential hypertension [ J ]. Hyperten.s,1994,12:113-139.
  • 5Schiffrin EL, Intengan I-ID, HibaultG. Clincal significance of endothelin in cardiovascular disease [ J ]. Curr Opinion Cordiol, 1997,12 : 354-367.
  • 6Ferro CJ, Webb DJ. Endothelial dysfunction and Hyperten.sion [J]. Drug, 1997,53:30-41.
  • 7Shapiro DA, Goldborg AI, Lipschutz KI, et al. Felodipine extended-release: efficacy through-out the dosing internal-the U. S experience[J]. Am J Hypertens, 1990, 3:113-116.
  • 8Hegner G, Faust G, Freytag F, et al. A new antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide [ J ]. Eur J Pharmacol, 1997, 52:173-176.
  • 9Yoshida H, Nadarnura M. Inhibition by angiotension converting enzyme inhibitors of endothelin secretion from cultured human endothelial [ J ]. Cells Life Sci,1992,50 : 195-202.
  • 10Lemischka IR, Pelosi A J, Dunniu MS, et al. Clonal in vivo behavior of the totipotent hematopotietic stem cell[J]. Semin Immunol, 1991,3:349-.352.

二级参考文献3

  • 1高连如,中华内科杂志,1995年,34卷,335页
  • 2高连如,中国高血压杂志,1994年,2卷,225页
  • 3高连如,中华心血管病杂志,1994年,22卷,86页

共引文献13

同被引文献10

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部